Mark J Mitton-Fry

12PUBLICATIONS
14CO-AUTHORS
Infectious agentsBiofabricationBasic pharmacologyMedical bacteriologyCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 23, 2026
In vitro and in vivo activity of OSUAB-0284, a preclinical candidate for Staphylococcus aureus infections.

|Dec 23, 2025
Activities of the Novel Bacterial Topoisomerase Inhibitor OSUAB-0284 against the Biothreat Pathogen Bacillus anthracis and Its Type II Topoisomerases.

Chelsea A Mann, Stephanie A Halasohoris, Annette M Gray

|Oct 19, 2025
Development of Selective and Soluble Mitochondrial Complex 1 Inhibitors Derived from Papaverine for Radiosensitization of Cancer.

Ben J Haines, McKenzie Kreamer, Martin Benej

|Apr 24, 2025
Decagram-Scale Synthesis of the Novel Bacterial Topoisomerase Inhibitor OSUAB-0284.

Jason S West, Chelsea A Mann, Mark J Mitton-Fry

|Apr 18, 2025
Structural and Mechanistic Insights into Atypical Bacterial Topoisomerase Inhibitors.

Paul D Toth, Steven C Ratigan, Joshua W Powell

|Jan 10, 2025
Anti-Mycobacterial Activity of Bacterial Topoisomerase Inhibitors with Dioxygenated Linkers.

Mark J Mitton-Fry, Jason E Cummings, Yanran Lu

Pageof 2

Frequent Collaborators

4 joint publications

Steffen Lindert

4 joint publications

Neil Osheroff

2 joint publications

Chelsea A Mann

1 joint publications

Jessica A Collins